Search by Drug Name or NDC
NDC 50090-5330-00 Clopidogrel 75 mg/1 Details
Clopidogrel 75 mg/1
Clopidogrel is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is CLOPIDOGREL BISULFATE.
MedlinePlus Drug Summary
Clopidogrel is used alone or with aspirin to prevent serious or life-threatening problems with the heart and blood vessels in people who have had a stroke, heart attack, or severe chest pain. This includes people who have percutaneous coronary intervention (PCI; angioplasty; a type of heart surgery) that may involve inserting coronary stents (metal tubes surgically placed in clogged blood vessels to improve blood flow) or who have coronary artery bypass grafting (CABG; a type of heart surgery). Clopidogrel is also used to prevent serious or life-threatening problems with the heart and blood vessels in people who have peripheral arterial disease (poor circulation in the blood vessels that supply blood to the legs). Clopidogrel is in a class of medications called antiplatelet medications. It works by preventing platelets (a type of blood cell) from collecting and forming clots that may cause a heart attack or stroke.
Related Packages: 50090-5330-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clopidogrel
Product Information
| NDC | 50090-5330 |
|---|---|
| Product ID | 50090-5330_05b466ea-5127-473e-b037-95e9ca9662b3 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Clopidogrel |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | clopidogrel bisulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLOPIDOGREL BISULFATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076274 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-5330-00 (50090533000)
| NDC Package Code | 50090-5330-0 |
|---|---|
| Billing NDC | 50090533000 |
| Package | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5330-0) |
| Marketing Start Date | 2020-11-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |